反応式
[NH2:1][C:2]1[C:10]([Cl:11])=[CH:9][C:5]([C:6]([OH:8])=[O:7])=[C:4]([O:12][CH3:13])[CH:3]=1.C([N:21]1[CH2:26][CH2:25][CH:24]([CH2:27]O)[CH2:23][CH2:22]1)C1C=CC=CC=1>C1COCC1.C([Li])CCC>[NH:21]1[CH2:26][CH2:25][CH:24]([CH2:27][O:7][C:6](=[O:8])[C:5]2[CH:9]=[C:10]([Cl:11])[C:2]([NH2:1])=[CH:3][C:4]=2[O:12][CH3:13])[CH2:23][CH2:22]1参加物
実験手順
1,1-carbonyldiimidazole (0.8 g., 0.005 mol) was added to a solution of 4-amino-5-chloro-2-methoxy-benzoic acid (1 g, 5 mmol) in THF (20 ml) and the reaction mixture was stirred at room temperature for about 30 minutes. The solvent was evaporated and the residue was taken up in H2O and extracted into ethyl acetate (3×20 ml). The organic phases were collected, dried and evaporated to dryness. The obtained solid residue was dissolved in THF (10 ml) and dropped into a solution of 1-benzylpiperidin-4-yl-methanol [J. Med. Chem. (1992), 35, 4344], (1 g, 5 mmol) in THF (10 ml) and butyllithium (1.6 M in hexane; 3 ml), maintained at 0° C. The reaction mixture was further stirred at room temperature for 1 hour. The solvent was evaporated and the residue was taken up into H2O and extracted into ethyl acetate. The organic extracts were dried and evaporated to give the desired product as a pale yellow oil, (1.63 g).
後処理
- customThe solvent was evaporated
- extractionextracted into ethyl acetate (3×20 ml)
- customThe organic phases were collected
- customdried
- customevaporated to dryness
- dissolutionThe obtained solid residue was dissolved in THF (10 ml)
- temperaturemaintained at 0° C
- stirringThe reaction mixture was further stirred at room temperature for 1 hour
- customThe solvent was evaporated
- extractionextracted into ethyl acetate
- customThe organic extracts were dried
- customevaporated
出典と根拠
- ORDレコード
- ord-7fd99fa515d346f1987bde2943c9f9dd
- 出典データセット
- uspto-grants-1999_12
- 特許番号
- US06002009
関連ノート
読み込み中…